Hannes Mikula

Title: Inventor Hannes Mikula - Pioneering Advances in PET Imaging

Introduction

Hannes Mikula, an innovative inventor based in Vienna, Austria, has made significant contributions to the field of medical imaging. With a focus on developing new imaging probes, his work is set to enhance the capabilities of positron emission tomography (PET) imaging through breakthrough solutions.

Latest Patents

Hannes Mikula holds a notable patent for "F-labeled novel tetrazines imaging probes for pretargeting in PET imaging." This patent presents novel F-labeled tetrazines that are remarkably reactive and effective for in vivo applications. These compounds are designed for pretargeted PET imaging, boasting impressive radiochemical yields that enable their clinical application. The innovative development employs a Cu-mediated click indirect labeling approach, ensuring accessibility and efficiency in clinical environments. Among the array of compounds explored, a specific compound featuring an F-labeled azide synthon linked to glucose, along with a triazole moiety, has demonstrated exceptional suitability for clinical pretargeted imaging.

Career Highlights

Hannes Mikula has garnered extensive experience working in esteemed institutions. Notably, he has been associated with Rigshospitalet and Københavns Universitet, where he has contributed to significant advancements in medical imaging technologies. His dedication and research efforts continue to push the boundaries of what is possible in the realms of PET imaging and diagnostics.

Collaborations

Throughout his career, Hannes has had the opportunity to collaborate with distinguished professionals in his field. Among his notable coworkers are Andreas Kjær and Matthias Manfred Herth, both of whom bring their expertise to enhance the collective efforts in developing innovative imaging solutions.

Conclusion

Hannes Mikula stands out as a prominent inventor making strides in the arena of medical imaging, particularly through his patent for F-labeled tetrazines. His collaborations with leading institutions and professionals signify a commitment to advancing healthcare technology. As the medical field continues to evolve, innovations like those of Hannes Mikula will undoubtedly play a crucial role in improving diagnostic capabilities and patient outcomes.